IdentificationGeneric Name(1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acidDrugBank Accession NumberDB03455Background(1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid is a solid. This compound belongs to the indole-3-acetic acid derivatives. These are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole. (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid is known to target interleukin-2.
TypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid (DB03455)× CloseWeightAverage: 266.316 Monoisotopic: 266.072513014 Chemical FormulaC12H14N2O3SSynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUInterleukin-2Not AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as indole-3-acetic acid derivatives. These are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole.KingdomOrganic compoundsSuper ClassOrganoheterocyclic compoundsClassIndoles and derivativesSub ClassIndolyl carboxylic acids and derivativesDirect ParentIndole-3-acetic acid derivativesAlternative ParentsAlpha amino acids and derivatives / 3-alkylindoles / Substituted pyrroles / Benzenoids / Heteroaromatic compounds / N-organohydroxylamines / Monocarboxylic acids and derivatives / Carboxylic acids / Azacyclic compounds / Alkylthiols / Organopnictogen compounds / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds


 show 4 moreSubstituents3-alkylindole / Alkylthiol / Alpha-amino acid or derivatives / Aromatic heteropolycyclic compound / Azacycle / Benzenoid / Carbonyl group / Carboxylic acid / Carboxylic acid derivative / Heteroaromatic compound / Hydrocarbon derivative / Indole / Indole-3-acetic acid derivative / Monocarboxylic acid or derivatives / N-organohydroxylamine / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Organosulfur compound / Pyrrole / Substituted pyrrole


 show 14 moreMolecular FrameworkAromatic heteropolycyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyFJAWIBGKKKXXAL-LLVKDONJSA-NInChIInChI=1S/C12H14N2O3S/c15-12(16)11(14-17-5-6-18)9-7-13-10-4-2-1-3-8(9)10/h1-4,7,11,13-14,18H,5-6H2,(H,15,16)/t11-/m1/s1IUPAC Name(2R)-2-(1H-indol-3-yl)-2-[(2-sulfanylethoxy)amino]acetic acidSMILES[H][C@](NOCCS)(C(O)=O)C1=CNC2=C1C=CC=C2ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound447066PubChem Substance46507395ChemSpider394263ZINCZINC000005889662PDBe LigandMPEPDB Entries1m4aClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.106 mg/mLALOGPSlogP1.27ALOGPSlogP1.55ChemaxonlogS-3.4ALOGPSpKa (Strongest Acidic)4.29ChemaxonpKa (Strongest Basic)2.44ChemaxonPhysiological Charge-1ChemaxonHydrogen Acceptor Count4ChemaxonHydrogen Donor Count4ChemaxonPolar Surface Area74.35 Å2ChemaxonRotatable Bond Count6ChemaxonRefractivity80.66 m3·mol-1ChemaxonPolarizability27.27 Å3ChemaxonNumber of Rings2ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.9923Blood Brain Barrier+0.8273Caco-2 permeable-0.6411P-glycoprotein substrateNon-substrate0.6219P-glycoprotein inhibitor INon-inhibitor0.9422P-glycoprotein inhibitor IINon-inhibitor0.9935Renal organic cation transporterNon-inhibitor0.8536CYP450 2C9 substrateNon-substrate0.8554CYP450 2D6 substrateNon-substrate0.7844CYP450 3A4 substrateNon-substrate0.724CYP450 1A2 substrateNon-inhibitor0.5429CYP450 2C9 inhibitorNon-inhibitor0.7117CYP450 2D6 inhibitorNon-inhibitor0.8421CYP450 2C19 inhibitorNon-inhibitor0.7303CYP450 3A4 inhibitorNon-inhibitor0.6723CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.718Ames testNon AMES toxic0.5222CarcinogenicityNon-carcinogens0.8846BiodegradationNot ready biodegradable0.9351Rat acute toxicity2.2816 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9489hERG inhibition (predictor II)Non-inhibitor0.7608  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted GC-MS Spectrum - GC-MSPredicted GC-MSNot AvailablePredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Interleukin-2KindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionKinase activator activitySpecific FunctionProduced by T-cells in response to antigenic or mitogenic stimulation, this protein is required for T-cell proliferation and other activities crucial to regulation of the immune response. Can stimu...Gene NameIL2Uniprot IDP60568Uniprot NameInterleukin-2Molecular Weight17627.52 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52 